RECRUITING

The Effects of Noninvasive Neuromodulation on Mental Wellness, Behavior, and Electrophysiology

Talk to us

Conditions

Anxiety Disorders

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the study is to test the effects of brief, low-intensity transcranial focused ultrasound (TUS) on electrophysiological, behavioral, and cognitive markers related to anxiety disorders.

Official Title

The Effects of Noninvasive Brain Stimulation on Mental States, Behavior, and Electrophysiology

Quick Facts

Study Start:2023-04-29
Study Completion:2024-04
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06169631

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18-65 years of age, as verified via photo identification with date of birth.
  2. * Should be an English speaker, as indicated by being able to read and comprehend the consent form.
  3. * Experiment 2 : Participants will be included for a past diagnosis of anxiety within the past year.
  1. * Smokes or uses tobacco products or any form of nicotine excessively
  2. * History of head injury with loss of consciousness for more than 5 min
  3. * Uncorrected hearing or vision impairment, including color blindness
  4. * Currently have or history of brain or mental illness judged likely to interfere with testing, including drug and/or alcohol dependence
  5. * History of epilepsy
  6. * Brain tumors
  7. * Takes medications or drugs judged likely to change brain activity, including psychoactive drugs, stimulants, benzodiazepines, and/or others
  8. * Factors that may lead to poor EEG or fNIRS recordings (e.g., hairstyle)
  9. * Inadequate sleep
  10. * Drug, alcohol or prescription drug intoxication, dependence or addiction
  11. * Pregnancy, or becoming pregnant during the course of the study
  12. * Mild cognitive impairment or impaired decision making
  13. * History of migraines
  14. * Experience with neurostimulation (which might unbind or alter the results)
  15. * Metal implants in their head or face

Contacts and Locations

Study Contact

Lisannette A Ruiz
CONTACT
520-343-1070
lisannette.r@sanm.ai
Stephanie French
CONTACT
650-417-8675
stephanie.f@sanm.ai

Principal Investigator

Jay Sanguinetti, PhD
PRINCIPAL_INVESTIGATOR
Sanmai Technologies PBC
Taylor Kuhn, PhD
PRINCIPAL_INVESTIGATOR
Sanmai Technologies PBC

Study Locations (Sites)

Sanmai Technologies PBC
Sunnyvale, California, 94087
United States

Collaborators and Investigators

Sponsor: Sanmai Technologies PBC dba Sanmai

  • Jay Sanguinetti, PhD, PRINCIPAL_INVESTIGATOR, Sanmai Technologies PBC
  • Taylor Kuhn, PhD, PRINCIPAL_INVESTIGATOR, Sanmai Technologies PBC

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-29
Study Completion Date2024-04

Study Record Updates

Study Start Date2023-04-29
Study Completion Date2024-04

Terms related to this study

Additional Relevant MeSH Terms

  • Anxiety Disorders